ERBB2 and breast cancer: A study that included 784 breast cancer patients who underwent surgical resection found high SII to be a poor prognostic factor for DFS and OS according to Kaplan–Meier survival curve analysis.[99] The study also analyzed the relationship between SII and clinicopathological characteristics and found that SII was also significantly associated with younger age, positive PR expression, and positive HER2 expression.